Boehringer Ingelheim’s Post

View organization page for Boehringer Ingelheim, graphic

1,816,366 followers

By embracing diversity in #ClinicalTrials, we enable more equitable and inclusive healthcare. How can this be achieved? Swipe right to learn more.

Elke Ydens

Associate Director Business Solutions bij Anju Software

1w

These are great points! Data is the cornerstone for addressing disparities and advancing health equity. Increased transparency will fuel decision-making. By leveraging comprehensive data, we can make informed, data-driven decisions that ensure diverse populations are adequately represented.  As an example, integrated global demographic and diversity data, including population and patient data, with clinical trial, site and investigator data streamlines global KOL, PI/site selection and diversity strategies. Key insights enhance clinical trial efficiency and help strive for more equitable healthcare.

Like
Reply
USA and international Research .

Chief Executive Officer at USA and International Research Inc.

2w

Diversity in clinical trials is crucial for equitable healthcare access. Let's ensure everyone's voice is heard! 

See more comments

To view or add a comment, sign in

Explore topics